Lipigon is a clinical-stage pharmaceutical company developing drugs for lipid-related diseases, focusing on conditions caused by disturbances in the body's handling of fats
Lipigon is a clinical-stage pharmaceutical company developing drugs for lipid-related diseases, focusing on conditions caused by disturbances in the body's handling of fats. Their leading candidate, Lipisense®, aims to lower triglyceride levels in patients with high levels, potentially reducing the risk of serious conditions like cardiovascular disease and type 2 diabetes.